MarketCapTrends
MYGN
Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare

Myriad Genetics Inc. Total Liabilities 2009–2025

Myriad Genetics Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Myriad Genetics Inc. total liabilities for the quarter ending December 31, 2025 were 338.6M, a 3.71% increase year-over-year.
  • Myriad Genetics Inc. total liabilities for 2025 were 338.6M, a 3.71% increase from 2024.
  • Myriad Genetics Inc. total liabilities for 2024 were 326.5M, a 10.13% decrease from 2023.
  • Myriad Genetics Inc. total liabilities for 2023 were 363.3M, a 16.11% increase from 2022.
  • Myriad Genetics Inc. total liabilities for 2022 were 312.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Myriad Genetics Inc. Annual Total Liabilities (Millions of US $)
2025$339
2024$327
2023$363
2022$313
2021$353
2020$538
2019$474
2018$209
2017$441
2016$132
2015$104
2014$105
2013$75
2012$55
2011$44
Myriad Genetics Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$339
2024-12-31$327
2023-12-31$363
2022-12-31$313
2021-12-31$353
2020-12-31$538
2020-06-30$486
2019-06-30$474
2018-06-30$209
2017-06-30$441
2016-06-30$132
2015-06-30$104
2014-06-30$105
2013-06-30$75
2012-06-30$55
2011-06-30$44
2010-06-30$36

Myriad Genetics Inc. Total Liabilities — FAQ

Myriad Genetics Inc. (MYGN) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MYGN's total liabilities history?

The chart and table above show Myriad Genetics Inc.'s total liabilities by year and by quarter, including the growth rate.